WiseGuyReports have announced the addition of a new report titled "2019 Global and Regional Liver Disease
Treatment Market Research Report Forecast 2025".
Medica Centre for Liver Disease
aims to meet a growing requirement for treatment of liver conditions, including transplant, in Eastern India.
The research that was published in the medical journal Gut last month looked into the various reasons for an (https://cms.ibtimes.com/diabetics-fatty-liver-higher-risk-cancer-cirrhosis-2800701) increase in liver disease
among the Americans between 1988 and 2016.
Arman Qamar, M.D., M.P.H., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues compared edoxaban with warfarin in 21,105 patients with AF followed for 2.8 years (5.1 percent with a history of liver disease
Biopharmaceutical company Dicerna Pharmaceuticals Inc (Nasdaq: DRNA) declared on Tuesday that it has submitted a Clinical Trial Authorization (CTA) application to the Swedish Medical Products Agency (MPA) to carry out a first-in-human Phase 1/2 study of DCR-A1AT, an investigational therapy from its GalXC technology platform, for alpha-1 antitrypsin (A1AT) deficiency-associated liver disease
The primary concern was to determine if current dosing protocols were appropriate for cats with liver disease
, as such cats comprise a large segment of the cats who might be prescribed this drug.
But another serious condition, non-alcoholic fatty liver disease
, is silently growing in prevalence, and its repercussions could be just as severe, top international doctors have warned.
Milk thistle extract has demonstrated benefits for non-alcoholic fatty liver disease
, alcoholic liver disease
, and cirrhosis.
Many expect that this technology will not only transform the approach to diagnosing and monitoring liver disease
but will also impact payer programs for population health management.
Younossi, MD, MPH, said in an interview in advance of the annual meeting of the American Association for the Study of Liver Diseases
. "Those two risk factors drive nonalcoholic fatty liver disease
(NAFLD) and its progressive type, nonalcoholic steatohepatitis (NASH).
Fatty Liver Disease
is rapidly becoming the most common liver disease
The latest figures from Public Health England have revealed that 1,579 adults under the age of 75 in the region died of liver disease
between 2014 and 2016, despite being relatively young.